Our CEO explains human cells as biological computers and how this concept will impact healthcare from drug discovery to new therapies and diagnostics.
05.01.2023
Going for growth by delivering the UK Science Superpower ambitions
In this blog for the BioIndustry Association, our CEO reflects on the opportunity for UK biotech to drive innovation and growth.
Behind the scenes at iGEM, the world's largest synbio competition for students!
Hear from bit.bio scientist Andreas Andreou what it was like to be a judge.
Beyond neurons - microglia cells and their role in neurodegeneration and neurodevelopment
The role of microglia cells in neurodegeneration and neurodevelopment featuring expert Dr Anthony Vernon.
.png)
How our culture enables scientists to bring in new technologies
Learn about the culture at bit.bio and how it enabled our manufacturing team to bring in new technology to improve our processes.
.png)
Reflecting on UKRI’s first five year strategy
In this blog post for the BioIndustry Association, our CEO reflects on UK Research and Innovation's 2022 strategy.
Addressing current challenges of in vitro cell models
In this blog, learn about current challenges of hiPSC-derived cell models, best approach for cell generation & future trends for h...
.png)
SynBio: the opportunity for UK Life Sciences
Our CEO writes about the importance of the synthetic biology industry as part of the UK Life Sciences vision. This was first publi...
Giving you easy access to endless and reliable human cells
Read this blog to learn how bit.bio are offering easy access to endless and reliable human cells for research and drug discovery.